Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2014
New materials help assess medicines policies and interventions
A new (and improved) model to regulate pharmaceutical promotion
Enhancing accountability in the medicines market: The Medicines Transparency Alliance
Bayer CEO's callous comments highlight failure of current biomedical innovation model
2013
When politicians go to the movies
2011
DG Trade State of Play reveals EU's ambitions for IP protection in FTAs
2010